[1]
K. Styczkiewicz, P. Plata, and K. Polityńska, “Should age disqualify from life-prolonging therapy? Successful adjuvant immunotherapy in an 88-year-old octogenarian with melanoma and high cardiovascular risk. ”, OncoReview, vol. 15, no. 4(60), pp. 62-66, Mar. 2026.